Cargando…
S156: FRONTLINE ASCIMINIB COMBINATION IN CHRONIC PHASE CHRONIC MYELOID LEUKEMIA PATIENTS. THE FASCINATION TRIAL.
| Autores principales: | , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428460/ http://dx.doi.org/10.1097/01.HS9.0000967536.34543.a6 |
| _version_ | 1785090474738974720 |
|---|---|
| author | Ernst, Thomas Le Coutre, Philipp Crysandt, Martina Brümmendorf, Tim H Franke, Georg-Nikolaus Illmer, Thomas Burchert, Andreas Lang, Fabian Saussele, Susanne Lars Teichmann, Lino Radsak, Markus Krause, Stefan Rinke, Jenny Fabisch, Christian Lang, Thomas Pfirrmann, Markus Hochhaus, Andreas |
| author_facet | Ernst, Thomas Le Coutre, Philipp Crysandt, Martina Brümmendorf, Tim H Franke, Georg-Nikolaus Illmer, Thomas Burchert, Andreas Lang, Fabian Saussele, Susanne Lars Teichmann, Lino Radsak, Markus Krause, Stefan Rinke, Jenny Fabisch, Christian Lang, Thomas Pfirrmann, Markus Hochhaus, Andreas |
| author_sort | Ernst, Thomas |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10428460 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104284602023-08-17 S156: FRONTLINE ASCIMINIB COMBINATION IN CHRONIC PHASE CHRONIC MYELOID LEUKEMIA PATIENTS. THE FASCINATION TRIAL. Ernst, Thomas Le Coutre, Philipp Crysandt, Martina Brümmendorf, Tim H Franke, Georg-Nikolaus Illmer, Thomas Burchert, Andreas Lang, Fabian Saussele, Susanne Lars Teichmann, Lino Radsak, Markus Krause, Stefan Rinke, Jenny Fabisch, Christian Lang, Thomas Pfirrmann, Markus Hochhaus, Andreas Hemasphere Oral Sessions Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428460/ http://dx.doi.org/10.1097/01.HS9.0000967536.34543.a6 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Oral Sessions Ernst, Thomas Le Coutre, Philipp Crysandt, Martina Brümmendorf, Tim H Franke, Georg-Nikolaus Illmer, Thomas Burchert, Andreas Lang, Fabian Saussele, Susanne Lars Teichmann, Lino Radsak, Markus Krause, Stefan Rinke, Jenny Fabisch, Christian Lang, Thomas Pfirrmann, Markus Hochhaus, Andreas S156: FRONTLINE ASCIMINIB COMBINATION IN CHRONIC PHASE CHRONIC MYELOID LEUKEMIA PATIENTS. THE FASCINATION TRIAL. |
| title | S156: FRONTLINE ASCIMINIB COMBINATION IN CHRONIC PHASE CHRONIC MYELOID LEUKEMIA PATIENTS. THE FASCINATION TRIAL. |
| title_full | S156: FRONTLINE ASCIMINIB COMBINATION IN CHRONIC PHASE CHRONIC MYELOID LEUKEMIA PATIENTS. THE FASCINATION TRIAL. |
| title_fullStr | S156: FRONTLINE ASCIMINIB COMBINATION IN CHRONIC PHASE CHRONIC MYELOID LEUKEMIA PATIENTS. THE FASCINATION TRIAL. |
| title_full_unstemmed | S156: FRONTLINE ASCIMINIB COMBINATION IN CHRONIC PHASE CHRONIC MYELOID LEUKEMIA PATIENTS. THE FASCINATION TRIAL. |
| title_short | S156: FRONTLINE ASCIMINIB COMBINATION IN CHRONIC PHASE CHRONIC MYELOID LEUKEMIA PATIENTS. THE FASCINATION TRIAL. |
| title_sort | s156: frontline asciminib combination in chronic phase chronic myeloid leukemia patients. the fascination trial. |
| topic | Oral Sessions |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428460/ http://dx.doi.org/10.1097/01.HS9.0000967536.34543.a6 |
| work_keys_str_mv | AT ernstthomas s156frontlineasciminibcombinationinchronicphasechronicmyeloidleukemiapatientsthefascinationtrial AT lecoutrephilipp s156frontlineasciminibcombinationinchronicphasechronicmyeloidleukemiapatientsthefascinationtrial AT crysandtmartina s156frontlineasciminibcombinationinchronicphasechronicmyeloidleukemiapatientsthefascinationtrial AT brummendorftimh s156frontlineasciminibcombinationinchronicphasechronicmyeloidleukemiapatientsthefascinationtrial AT frankegeorgnikolaus s156frontlineasciminibcombinationinchronicphasechronicmyeloidleukemiapatientsthefascinationtrial AT illmerthomas s156frontlineasciminibcombinationinchronicphasechronicmyeloidleukemiapatientsthefascinationtrial AT burchertandreas s156frontlineasciminibcombinationinchronicphasechronicmyeloidleukemiapatientsthefascinationtrial AT langfabian s156frontlineasciminibcombinationinchronicphasechronicmyeloidleukemiapatientsthefascinationtrial AT sausselesusanne s156frontlineasciminibcombinationinchronicphasechronicmyeloidleukemiapatientsthefascinationtrial AT larsteichmannlino s156frontlineasciminibcombinationinchronicphasechronicmyeloidleukemiapatientsthefascinationtrial AT radsakmarkus s156frontlineasciminibcombinationinchronicphasechronicmyeloidleukemiapatientsthefascinationtrial AT krausestefan s156frontlineasciminibcombinationinchronicphasechronicmyeloidleukemiapatientsthefascinationtrial AT rinkejenny s156frontlineasciminibcombinationinchronicphasechronicmyeloidleukemiapatientsthefascinationtrial AT fabischchristian s156frontlineasciminibcombinationinchronicphasechronicmyeloidleukemiapatientsthefascinationtrial AT langthomas s156frontlineasciminibcombinationinchronicphasechronicmyeloidleukemiapatientsthefascinationtrial AT pfirrmannmarkus s156frontlineasciminibcombinationinchronicphasechronicmyeloidleukemiapatientsthefascinationtrial AT hochhausandreas s156frontlineasciminibcombinationinchronicphasechronicmyeloidleukemiapatientsthefascinationtrial |